Cellectis

Medicago Inc.

Cellectis S.a.

Global Bioenergies

Luc Mathis

Feng Zhang

Daniel F Voytas

Thomas Stoddard

William Haun

Marc-Andre D'Aoust

Jin Li

Marc Lemaire

Serge Ratton

Benjamin Clasen

Zachary Demorest

Estelle Metay

Marc-Andre D'aoust

The present application relates to a compound of the following formula (I)

Carbonyl compounds, methods for preparing same and uses thereof

Materials and methods are provided for making plants (e.g.,varieties) that are suitable for producing therapeutic polypeptides suitable for administration to humans and animals, particularly by making TAL effector endonuclease-induced mutations in genes encoding xylosyltransferases and fucosyltransferases.

Mutantplant or cell with reduced XylT and FucT

Method for making nicotiana plants with mutations in XylT and FucT alleles using rare-cutting endonucleases

Materials and methods are provided for making soybean varieties that have altered oil composition as a result of mutations in the FAD3A, FAD3B, and FAD3C genes.

Modifying soybean oil composition through targeted knockout of the FAD3A/B/C genes

Materials and methods are provided for makingvarieties with decreased accumulation of reducing sugars and acrylamide in cold-stored potatoes, specifically, by making TALE-nuclease-induced mutations in genes encoding vacuolar invertase.

Potatoes with reduced cold-induced sweetening

Materials and methods are provided for making soybean varieties that have altered oil composition as a result of mutations in the FAD2-1A and FAD2-1B genes.

Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes

Growing community of inventors

Le Kremlin Bicetre, France

Luc Mathis